发明名称 Lactam glycogen phosphorylase inhibitors and method of use
摘要 A compound of formula I wherein W is a bicyclic hetroaryl of the structure X is -O-, -S-, -SO<SUB>2</SUB>-, -CHR<SUP>5</SUP>-, -CHR<SUP>5</SUP>O-, -CHR<SUP>5</SUP>S-, -CHR<SUP>5</SUP>SO<SUB>2</SUB>-, -CHR<SUP>5</SUP>CO- or -CH<SUB>2</SUB>CHR<SUP>5</SUP>-; Y is a bond or -CHR<SUP>6</SUP>-; Z is an aryl or heteroaryl group of the following structure: A is -CH- or -N-; B is -O- or -S-; and R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5</SUP>, R<SUP>6</SUP>, R<SUP>7 </SUP>and R<SUP>8 </SUP>are as described herein. Further provided is a method for treating diabetes and related diseases employing a glycogen phosphorylase inhibiting amount of the above compound, either alone or in combination with another therapeutic agent.
申请公布号 US2006128687(A1) 申请公布日期 2006.06.15
申请号 US20060352867 申请日期 2006.02.13
申请人 SHER PHILIP;WU GANG;STOUCH TERRY;ELLSWORTH BRUCE 发明人 SHER PHILIP;WU GANG;STOUCH TERRY;ELLSWORTH BRUCE
分类号 A61K31/554;A61K31/496;A61K31/5377;A61K31/541;A61K45/06;C07D209/42;C07D401/12;C07D403/12;C07D403/14;C07D413/12;C07D417/02;C07D417/12;C07D471/04;C07D498/04;C07D513/04 主分类号 A61K31/554
代理机构 代理人
主权项
地址